The treatment for prostate cancer may change after Scientists found out that there are five distinct types of prostate cancer, which can be treated according to its characteristics, this according to Cancer Research UK.
According to the research team of Cancer Research Cambridge Institute in UK, they have been able to distinguish the tumors of prostate cancer into five group base on the genetic mutation.
The study was collected from 250 men, using their cancerous prostate tissue, according to the analytical findings from 100 genes, there's a possibility that doctors can adjust the way they treated the prostate cancer according to their characteristics.
Although the latest analysis was far better than the previous tests, experts suggest that the findings need to run more trials with a larger group of men for confirmation.
Dr. Alastair Lamb, study author from Cancer Research UK said, "Our exciting results show that prostate cancer can be classified into five genetically-different types. These findings could help doctors decide on the best course of treatment for each individual patient, based on the characteristics of their tumour."
The Lamb added, "The next step is to confirm these results in bigger studies and drill down into the molecular 'nuts and bolts' of each specific prostate cancer type. By carrying out more research into how the different diseases behave we might be able to develop more effective ways to treat prostate cancer patients in the future, saving more lives."
Prostate cancer expert, Professor Malcolm Mason said that the challenging part of treating prostate cancer is the erratic behavior of this illness.
Further adding, "This research could be game-changing if the results hold up in larger clinical trials and could give us better information to guide each man's treatment - even helping us to choose between treatments for men with aggressive cancers. Ultimately this could mean more effective treatment for the men who need it, helping to save more lives and improve the quality of life for many thousands of men with prostate cancer."
